Science Explorer Interactive view Map
Company · Lianyungang · China

Jiangsu Hengrui Medicine (China)

In research, Jiangsu Hengrui Medicine (China) stands highest in Medicine (#4,938 of 10,443 worldwide) and Health Sciences (#6,604 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 16.4× its share of world research.

hrs.com.cn/englishROR OpenAlex
World rank, 2022–2025
#12,225
of 28,054 · #22,731 all time
Rank in China
#2,120
of 3,058
Research works
357
▲ 132% vs 2013–17
Citations
4.7k
13.3 per fractional work
Top-10% rate
17.3%
record average 16.5%
Open access
40%
world 28%

What is Jiangsu Hengrui Medicine (China) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #4,938 of 10,443 20.0%96 #10221
Health SciencesDomain #6,604 of 11,982 20.2%97 #13336

Each strip is that field’s whole ranked pool, with the notch where Jiangsu Hengrui Medicine (China) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Jiangsu Hengrui Medicine (China) specialise in?

Where its research is concentrated relative to its size: Oncology takes 16.4× the share of its output that it takes of world research.

  1. OncologySubfield · 32.3 works16×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.31× its world share, 3 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.01× its world share, 28 worksBiochemistry, Geneti…Immunology and Microbiology: 3.70× its world share, 6 worksImmunology and Micro…Neuroscience: 0.96× its world share, 3 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.58× its world share, 4 worksPharmacology, Toxico…Chemical Engineering: 1.18× its world share, 1 worksChemical EngineeringChemistry: 2.63× its world share, 7 worksChemistryComputer Science: 0.24× its world share, 3 worksComputer ScienceEarth and Planetary Sciences: 0.04× its world share, 0 worksEarth and Planetary …Energy: 0.17× its world share, 0 worksEnergyEngineering: 0.52× its world share, 14 worksEngineeringEnvironmental Science: 0.18× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.77× its world share, 5 worksMaterials ScienceMathematics: 0.85× its world share, 2 worksMathematicsPhysics and Astronomy: 0.09× its world share, 0 worksPhysics and AstronomyDentistry: 0.08× its world share, 0 worksDentistryHealth Professions: 0.05× its world share, 0 worksHealth ProfessionsMedicine: 2.83× its world share, 96 worksMedicineNursing: 0.41× its world share, 0 worksNursingVeterinary: 0.81× its world share, 0 worksVeterinaryDecision Sciences: 0.17× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.16× its world share, 1 worksEconomics, Econometr…Psychology: 0.04× its world share, 0 worksPsychologySocial Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.6×. Every wedge is a field page.

Who are the top researchers at Jiangsu Hengrui Medicine (China)?

Ranked on the composite score, Sheng Feng and Feng He lead among researchers whose main affiliation is Jiangsu Hengrui Medicine (China).

  1. 1 Sheng Feng China · #1,276,212 worldwide 29 citations · 16 works
  2. 2 Feng He China · #1,478,801 worldwide 7 citations · 15 works
All ranked researchers at Jiangsu Hengrui Medicine (China)

Which keywords describe research at Jiangsu Hengrui Medicine (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Tumor Microenvironment, Monoclonal Antibodies, Breast Cancer, Targeted Therapy, Immunotherapy, Therapeutic Antibodies and Cancer Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy18▲ 15×17 topics
  2. Tumor Microenvironment12▲ 16×7 topics
  3. Monoclonal Antibodies12▲ 76×3 topics
  4. Breast Cancer11▲ 27×7 topics
  5. Targeted Therapy11▲ 29×5 topics
  6. Immunotherapy11▲ 8.8×14 topics
  7. Therapeutic Antibodies10▲ 83×2 topics
  8. Cancer Therapy10▲ 9.7×15 topics
  9. Clinical Trials10▲ 8.2×10 topics
  10. Inflammation10▲ 2.6×37 topics
  11. Cancer9▲ 3.6×27 topics
  12. Glycosylation7▲ 38×3 topics
  13. Metastatic Breast Cancer7▲ 72×2 topics
  14. PET Imaging7▲ 23×4 topics
  15. Biomarkers7▲ 5.7×10 topics
  16. Metastatic7▲ 62×2 topics
  17. Monoclonal Antibody7▲ 74×2 topics
  18. Immune Checkpoint Blockade7▲ 34×1 topic
  19. PD-1 and PD-L17▲ 34×1 topic
  20. Biopharmaceuticals6▲ 72×3 topics
  21. HER26▲ 129×1 topic
  22. Trastuzumab6▲ 81×1 topic
  23. Immunogenicity6▲ 84×2 topics
  24. Prognostic Factors6▲ 7.9×12 topics
  25. Antibody Engineering6▲ 59×1 topic
  26. Fc Receptors6▲ 59×1 topic
  27. Metastasis6▲ 9.3×10 topics
  28. Clinical Practice Guidelines5▲ 5.6×9 topics
  29. Survival Analysis5▲ 11×6 topics
  30. Neoadjuvant Therapy5▲ 12×5 topics
  31. Genomic Profiling5▲ 26×2 topics
  32. Recombinant Proteins5▲ 84×2 topics
  33. Protein Aggregation4▲ 48×1 topic
  34. Stability4▲ 11×1 topic
  35. CDK4/6 Inhibitors4▲ 97×1 topic
  36. Palbociclib4▲ 97×1 topic
  37. Cancer Treatment4▲ 10×5 topics
  38. Medicinal Chemistry4▲ 8.3×6 topics
  39. Resistance Mechanisms4▲ 27×2 topics
  40. Pharmacokinetics4▲ 8.4×5 topics

Which research topics does Jiangsu Hengrui Medicine (China) publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research and Protein purification and stability.

Cancer Immunotherapy and…7Cancer Immunotherapy and Biomarkers: 7 fractional worksHER2/EGFR in Cancer Rese…6HER2/EGFR in Cancer Research: 6 fractional worksMonoclonal and Polyclona…6Monoclonal and Polyclonal Antibodies Research: 6 fractional worksProtein purification and…4Protein purification and stability: 4 fractional worksAdvanced Breast Cancer Therapies: 4 fractional worksLung Cancer Treatments and Mutations: 4 fractional worksRadiopharmaceutical Chem…4Radiopharmaceutical Chemistry and Applications: 4 fractional worksCancer Treatment and Pharmacology: 3 fractional worksLung Cancer Research Studies: 3 fractional worksPeptidase Inhibition and Analysis: 2 fractional works
OncologyRadiology, Nuclear Medicine and ImagingMolecular BiologyPulmonary and Respiratory Medicine

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 7 works
  2. 2 HER2/EGFR in Cancer Research Oncology 6 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 6 works
  4. 4 Protein purification and stability Molecular Biology 4 works
  5. 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 4 works
  6. 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
  7. 7 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 4 works
  8. 8 Cancer Treatment and Pharmacology Oncology 3 works
  9. 9 Lung Cancer Research Studies Oncology 3 works
  10. 10 Peptidase Inhibition and Analysis Oncology 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.2%not open59.8%

World: 28% of research is openly available.

with international co-authors12.0%domestic only88.0%

World: 19% is written across borders.

How has Jiangsu Hengrui Medicine (China)'s research output changed?

Output in 2018–2022 was 132% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lianyungang

All research institutions in Lianyungang

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.